Description: Sansure Biotech Inc. engages in the research and development, production, and sale of in-vitro diagnostic reagents and ancillary instruments in China. The company offers Hepatitis B virus nucleic acid detection kits, fully automatic nucleic acid extraction system, real-time fluorescent quantitative PCR analysis system, fully automatic cup and liquid processing system, mobile molecular diagnostic system, and high-throughput sequencing system. It also provides genetic testing services; next generation sequencing services; bioinformatics analysis services; and postdoctoral recruitment and scientific research cooperation services, as well as third-party medical testing services. The company was founded in 2008 and is headquartered in Changsha, China.
Home Page: www.sansure.com.cn
No. 680, Lusong Road
Changsha,
410205
China
Phone:
86 73 1888 8317
Officers
| Name | Title |
|---|---|
| Mr. Lizhong Dai | Chairman & GM |
| Mr. Peng Zhu | CFO, Deputy GM, Board Sec. & Director |
| Mr. Xialin Yu | Deputy GM & Director |
| Mr. Xu Fan | Deputy GM & Director |
| Ms. Jun Zhou | Deputy GM & Chief Medical Officer |
| Mr. Yanhuan Wan | Deputy Gen. Mang. |
| Mr. Jia Liu | Deputy Gen. Mang. |
| Mr. Liu Kai | Deputy Gen. Mang. |
| Mr. Jian Zhu | Deputy Gen. Mang. |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 6.3559 |
| Price-to-Book MRQ: | 1.846 |
| Price-to-Sales TTM: | 2.6946 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1729 |